ImmunityBio, Inc. (IBRX)
8.39
+0.57
(+7.29%)
USD |
NASDAQ |
Mar 13, 16:00
8.39
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio Market Cap : 8.626B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 879.67B |
| Merck & Co., Inc. | 285.83B |
| Iovance Biotherapeutics, Inc. | 1.631B |
| Krystal Biotech, Inc. | 7.228B |
| Arcellx, Inc. | 6.690B |
Market Cap Related Metrics
| PS Ratio | 68.09 |
| Price | 8.39 |
| Earnings Yield | -4.65% |